NCT07277413 2026-01-20A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid TumorsIDEAYA BiosciencesPhase 1 Recruiting260 enrolled
NCT05324436 2025-01-20A Study of Yervoy and Opdivo Combination Therapy in Participants With Unresectable Advanced/Recurrent Malignant Pleural Mesothelioma (MPM)Bristol-Myers SquibbCompleted75 enrolled
NCT03538028 2020-10-30A Safety and Tolerability Study of INCAGN02385 in Select Advanced MalignanciesIncyte CorporationPhase 1 Completed22 enrolled
NCT00597116 2016-10-10An Efficacy and Safety Study With Vandetanib to Treat Inoperable or Relapsed Malignant MesotheliomaSanofiPhase 2 Terminated25 enrolled 8 charts
NCT01271959 2012-10-05A Study of ChemoFx® Chemoresponse Assay in Solid Tumors - ChemoFx® Registry StudyPrecision TherapeuticsTerminated167 enrolled